Pillsbury Winthrop Shaw Pittman LLP advised Sentynl Therapeutics on the deal. Sentynl Therapeutics, a USA-based specialty pharma company owned by the India’s Zydus Group, announced the agreement...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here